- CA$2.65bn
- CA$2.95bn
- CA$1.26bn
- 80
- 81
- 81
- 95
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 558 | 408 | 820 | 1,547 | 1,263 |
Cost of Revenue | |||||
Gross Profit | 380 | 226 | 617 | 1,255 | 939 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 507 | 647 | 349 | 666 | 746 |
Operating Profit | 50.6 | -240 | 471 | 881 | 517 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -103 | -254 | 345 | 814 | 476 |
Provision for Income Taxes | |||||
Net Income After Taxes | -63.8 | -198 | 265 | 631 | 368 |
Net Income Before Extraordinary Items | |||||
Net Income | -63.8 | -198 | 265 | 631 | 368 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -63.8 | -198 | 265 | 631 | 368 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.292 | -0.33 | 1.03 | 2.67 | 1.61 |